Nova Laboratories Limited
Mike Edge currently serves as the Head of Non Sterile Manufacturing at Nova Laboratories Limited, a position held since August 2012, where responsibilities include leading the manufacture and development of licensed products and the contract manufacture of clinical trial products. Previously, Mike managed the Non Sterile Compounding Unit, focusing on the production of non-licensed specials and small batches for clinical trials and commercial customers, including cytotoxic products. Prior experience at 3M Health Care from July 1998 to September 2012 involved roles as a Technical Project Manager specializing in skin health and infection prevention, and as a Development Specialist overseeing the development and production of semisolid pharmaceutical products. Mike's educational background includes a Ph.D. in Pharmaceutics from the University of Bradford and a B.Sc. in Pharmacy from The University of Manchester.
This person is not in any teams
This person is not in any offices
Nova Laboratories Limited
Nova Laboratories is an independent contract manufacturer, that has established a worldwide reputation, for the aseptic processing of pharmaceutical, biotechnology and medical device products. This has been achieved as a result of it having a demonstrable track record of successfully applying its processes and technology to a significant number of challenging and novel applications. Nova is one of the UK's leading independent providers of services to both the Pharmaceutical and Biotechnology sectors, and currently has Aseptic Processing Capability for: Emulsion manufacturing Fill / Finish of Antibodies, Peptides, Plasmids & Proteins Live Biologics Lyophilisation Medical Device assembly Powder blending and filling Spray Drying Syringe Filling Vial & Ampoule Filling As well as it's aseptic manufacturing, Nova also has the facilities and expertise to offer the following non sterile manufacturing: Specials Clinical Trial materials Contract Manufacturing More recently, through its affiliate Nova Bio-Pharma Technologies Limited, Nova has gained access to two patented technologies that are aimed at making a variety of materials, but particularly Pharmaceutical and biotechnology ones, thermally stable at tropical temperatures i.e. remove the need for cold chain storage and distribution. We also offer QP release, clinical trial labelling, process & formulation development, analytical services and expert technicla assistance, in support of our manufacturing operations.